NeoGenomics Price to Book Value: 5.923 for June 3, 2020. FORT MYERS, FL / ACCESSWIRE / October 29, 2019 / NeoGenomics, Inc. (NASDAQ: ... Average cost of goods sold per clinical test ("cost per test") increased by … X When looking for the best stocks to buy and watch , be sure to pay attention to relative price strength. The Company provides one of the most comprehensive oncology-focused testing menus in the world for physicians to help them diagnose and treat cancer. The brokerage presently has a “buy” rating on the medical research company’s stock. FT. MYERS, FL -- (Marketwired) -- 10/25/17 -- NeoGenomics, Inc. (NASDAQ: NEO), a leading provider of cancer-focused genetic testing services, today reported its results for the third quarter of 2017. Probes may be ordered separately except +8 and…. The NeoTYPE Bloomberg the Company & Its Products The Company & its Products Bloomberg Terminal Demo Request Bloomberg Anywhere Remote Login Bloomberg Anywhere Login Bloomberg Customer Support Customer Support NEOGENOMICS, INC. () : Stock quote, stock chart, quotes, analysis, advice, financials and news for share NEOGENOMICS, INC. | Boerse Stuttgart: NG9 | Boerse Stuttgart Analysis includes detection of all mutations recommended by…, Anti-adrenocorticotropic hormone (ACTH) is a useful marker in the classification of pituitary tumors and the study of pituitary disease. NeoGenomics has a national footprint and broad customer reach in cancer-related genetic testing services and one of the most comprehensive oncology-focused test menus. Subscribe to this site. Historical daily share price chart and data for NeoGenomics since 2020 adjusted for splits. Probes: RUNX1/RUNX1T1 (ETO/AML1) t(8;21) | PML/RARA t(15;17) | CBFB inv(16), t(16;16) Available as global and tech-only. This suggests that the stock has a possible downside of 14.7%. By the numbers. , and has now gained 4 days in a row.It will be exciting to see whether it manages to continue gaining or take a minor break for the next few days. ET by Tomi Kilgore Like Amazon, these stocks have 100% buy ratings from analysts The NeoGenomics stock price gained 1.10% on the last trading day (Friday, 11th Dec 2020), rising from $50.20 to $50.75. Disease(s): Follicular Lymphoma (FL), Alpha-1-Antitrypsin (AAT) is useful in the study of inherited AAT deficiency, benign and malignant hepatic tumors and yolk sac carcinoma. 10 Wall Street analysts have issued twelve-month price objectives for NeoGenomics' shares. NeoGenomics stock is the IBD Stock Of The Day as the cancer-testing outlet breaks out on a never-higher relative strength line.. X. On average, they anticipate NeoGenomics' share price to reach $40.95 in the next twelve months. Consolidated operating expenses increased by $3.5 million, or 13%, from Quarter 2 2016, primarily as a result of increased payroll, depreciation, non-cash stock-based compensation, and bad debt expenses. About Genomic Cancer Testing View real-time stock prices and stock quotes for a full financial overview. About NeoGenomics, Inc. NeoGenomics, Inc. specializes in cancer genetics testing and information services. Call the NeoGenomics Client Services team at 866.776.5907 and press 3 to order test requisitions and kits, or to inquire about setting up online ordering through NeoLINK® Sorry for the convenience. Probes: TCF3/PBX1 (E2A/PBX1) t(1;19) | Trisomy or Tetrasomy 4, 6, 10, 17 (Cen 4, Cen 6, Cen 10, Cen 17) | MYC (8q24) | BCR/ABL1/ASS1 t(9;22) | MLL (11q23) | IgH (14q32) | Available as global and tech-only. Gross margin declined to 43.7%, primarily due to higher average cost per test of Clinical Services and the timing of Pharma Services revenue. NeoGenomics (NASDAQ:NEO) had its price objective lifted by analysts at Benchmark from $40.00 to $48.00 in a research report issued on Wednesday, Benzinga reports. Average cost-of-goods-sold per clinical genetic test ("Cost per Test") declined by 10% compared to the first quarter of 2016, which led to a slight improvement in gross margin for this business. NeoGenomics, Inc. 44.9600 USD 4.39% 44.9600 USD 4.39% 20.4700 44.7500 52 weeks 52 weeks Mkt Cap 4.62B. NeoGenomics is a leading oncology genetics reference lab. Test Updates . Probes: TNFRSF14 (1p36) Receive weekly updates on NeoGenomics tests, research, events, and publications. Acid-fast techniques are of value in the detection of mycobacteria, rod-shaped organisms that sometimes exhibit…, Alpha-1-fetoprotein (AFP) is a 64 kD tumor-associated embryonal antigen produced by fetal liver, hepatocellular carcinoma, yolk sac tumor and several germ cell tumors of testicular and ovarian origin. Disease(s): Oligodendroglioma It boasts 10 global locations, serves 2,600 hospitals, and processes 1 million tests annually. Shares of NeoGenomics gained 74% in the first six months of the year, according to data provided by S&P Global Market Intelligence. 10 Wall Street analysts have issued twelve-month price objectives for NeoGenomics' shares. Probes may be ordered separately. Average cost-of-goods-sold per clinical genetic test ("Cost per Test") declined by 13% compared to the second quarter of 2016. Test Description The NeoTYPE Liver/Biliary Tumor Profile analyzes 38 biomarkers through a combination of next-generation sequencing (NGS), FISH, and IHC as listed below. T: 239.768.0600 NEW YORK (GenomeWeb) – NeoGenomics said after the close of the market on Tuesday that is has priced its previously announced underwritten public offering of 7 million shares of its common stock at a public offering price of $21.25 per share.. Probes may be ordered separately. Flow Cytometry. FT. MYERS, FL / ACCESSWIRE / June 29, 2020 / NeoGenomics, Inc. (NASDAQ:NEO), a leading provider of cancer-focused genetic testing services, announced … The all-time high NeoGenomics stock closing price was 43.94 on October 15, 2020.; The NeoGenomics 52-week high stock price is 44.58, which is 3.9% above the current share price. Disease(s): Acute lymphoblastic (lymphocytic) leukemia (B-cell ALL), B…, Probes: PDGFRb (5q32), BCR/ABL1-ASS1 t(9;22), JAK2 (9p24.1), EPOR (19p13.2) and CRLF2 (Xp22.33/Yp11.32) are included in the ALL FISH (Ph-like) Panel. It reacts with ACTH-producing cells (corticotrophs). Ziehl-Neelsen Acid-Fast Bacilli Stain is used to detect the presence of acid-fast mycobacteria in tissue sections. FNA/CSF Short T/B Panel (referred in the Flow User’s Guide as Short Sample T/B Panel) – The flow workbook for the test has been updated to have the same format and page order as the Standard/Ext workbook. New Tests. View 4,000+ financial data types. $48.01 $0.10 0.2% Price as of December 4, 2020, 9:00 p.m. EST View Interactive NEO Charts NeoGenomics is a provider of genetic testing, specializing in cancer diagnostics. T: 239.768.0600 The test is called a "companion" diagnostic because it aims to detect mutations and provide patients quick access to Piqray, a recently approved drug targeting PIK3CA from Novartis. NeoGenomics stock price up 1.1% on Friday (Updated on December 11, 2020) Buy or Hold candidate since 2020-11-03 Gain 27.58% PDF . Third Quarter 2017 Highlights: 17% increase in clinical genetic testing volume (1); 4% increase in consolidated revenue to $63.1 million "Our core business is strong, we expect modest price-per-test … Disease(s): Philadelphia chromosome (Ph-like) acute lymphoblastic…, Probes: TCF3/PBX1 (E2A/PBX1) t(1;19) | Trisomy or Tetrasomy 4, 6, 10, 17 (Cen 4, Cen 6, Cen 10, Cen 17) | MYC (8q24) | BCR/ABL1/ASS1 t(9;22) | MLL (11q23) | ETV6/RUNX1 (TEL/AML1) t(12;21) | IgH (14q32) Share price has grown by more than 50% since November to a current high of $29.84. This add-on panel is available to clarify findings on samples currently having flow cytometry analysis at NeoGenomics and is not available for stand-alone testing. NeoGenomics has converted a portion of its lab space to run up to 10,000 SARS-CoV-2 diagnostic tests per day, which could increase in the future. Barron's also provides information on historical stock ratings, target prices, company earnings, market valuation and more. F: 239.690.4237. Disease(s…, Probes: 5q-, -5 (5p15, 5q31, 5q33) | 7q-, -7 (Cen 7, 7q22, 7q31) | Trisomy 8 (Cen 8) | MLL (11q23) | 20q- (20q12, 20qter) | RUNX1/RUNX1T1 (ETO/AML1) t(8;21) | PML/RARA t(15;17) | CBFB inv(16), t(16;16) The current P/S ratio for NeoGenomics as of November 11, 2020 is . Gross proceeds to NeoGenomics from the offering are expected to be $148.8 million. Please select your favorite tests to print a custom catalog. For more information, visit www.Test4TRK.com. 12701 Commonwealth Dr., Suite 9 View analysts' price targets for NeoGenomics. Gross profit decreased slightly by $0.7 million, or 1.6%, compared to the first quarter of 2019, to $46.4 million. 12701 Commonwealth Dr., Suite 9 LabCorp's test menu provides a comprehensive list of specialty and general laboratory testing services. This suggests that the stock has a possible downside of 14.7%. HER2 IHC, HER2 FISH, and NeoTYPE ® Cancer Profiles: Changes … Shares Out 103.35M. VENTANA FDA approved ALK (D5F3) CDx Assay is intended for the qualitative detection of the anaplastic lymphoma kinase (ALK) protein in formalin-fixed, paraffin-embedded (FFPE) non-small cell lung carcinoma (NSCLC) tissue stained with a BenchMark XT…, Probes: ALK (2p23) NeoGenomics Slumps in Q2 but Readies for Second-Half Rebound The oncology reference lab never stopped investing in near- and long-term opportunities. NeoGenomics is a pure-play oncology reference lab. If you delete your browser cookies, you will need to rebuild your test list. Importantly, test volume in our core clinical (1) oncology business continued to trend higher on what looks to be a V-Shaped recovery and the majority of our pharma clients' clinical trial sites are now open," said Douglas M. VanOort, Chairman and CEO of NeoGenomics. To have a better experience, please upgrade to Microsoft Edge, Google Chrome, or Firefox. Set Alert Options Streaming Charts. Gross profit decreased slightly by $0.7 million, or 1.6%, compared to the first quarter of 2019, to $46.4 million. NeoGenomics will commercialize the InVisionFirst-Lung liquid biopsy test in the United States . ... as that will allow us to continue our long-term improvement in cost per test… The latest closing stock price for NeoGenomics as of November 10, 2020 is 42.90.. The… The Company provides one of the most comprehensive oncology-focused testing menus in the world for physicians to help them diagnose and treat cancer. In depth view into NeoGenomics Year to Date Price Returns (Daily) including historical data from 1999, charts, stats and industry comps. Disease(s): Anaplastic large cell lymphoma, NHL, Probes: ALK (2p23) Markers are cCD3, cCD22, cCD79, CD11b, CD123, CD34… NeoGenomics, Inc. specializes in cancer genetic testing and information services. nCounter PanCancer Immune Profiling Panel, DNA Hybridization Capture Target Enrichment, Medical Necessity for BCR-ABL Negative Myeloproliferative Disease, Medical Necessity for NRAS Genetic Testing, Medical Necessity for Next-Generation Sequencing (NGS) for Myeloid and Suspected Myeloid Malignancies, Medical Necessity for Next-Generation Sequencing (NGS) for Solid Tumors, Prior Authorization Insurance Plans and CPT Codes, Precision Medicine in the COVID-19 Crisis. Bayer will cover the full cost of the test regardless of the test results, treatment decision and patient’s insurance coverage for up to 500 patients in the U.S. Bayer will not cover the associated costs of extracting a viable tumor specimen. Clients who decline full phenotyping and…, Probes: RPN1, MECOM (3q21, 3q26.2) | 5q-, -5 (5p15, 5q31, 5q33 | 7q-, -7 (Cen 7, 7q22, 7q31) | Trisomy 8 (Cen 8) | DEK/NUP214 (CAN) t(6;9) | MLL (11q23) | ETV6 (12p13) | 17p- (TP53 17p13.1, NF1 17q11.2) | Probes may be ordered separately. Sensitivity and specificity of the results have made this antibody a useful tool in the screening of patients…, RT-PCR and sequencing of the BCR-ABL1 fusion transcript for qualitative detection of mutations associated with resistance to Gleevec (imatinib) and other tyrosine kinase inhibitors. Special stain. Disease(s): B-cell non-Hodgkin lymphoma. The company, which … Benchmark’s target price would indicate a potential upside of 16.36% from the company’s previous close. NeoGenomics stock price target raised to $48 from $40 at Benchmark Oct. 28, 2020 at 6:13 a.m. Ft. Myers, Florida – December 10, 2018 – NeoGenomics, Inc. (NASDAQ: NEO), a leading provider of cancer-focused genetic testing services, announced today that it has completed the acquisition of the parent company of Genoptix, Inc. for $125 million in cash, as adjusted by working capital and other adjustments, and 1 million shares of NeoGenomics common stock. F: 239.690.4237. The business offers a comprehensive menu of laboratory tests doctors typically use to diagnose, monitor, and assess the … Probes: CEN 11 (11p11.1-q11) | MLL (11q23) | 11qTel (11q25) As you browse our test menu, and you see your preferred test, simply select the Add to Favorites button. 37% Increase in Pharma Services Revenue. On average, they anticipate NeoGenomics' share price to reach $40.95 in the next twelve months. About Genomic Cancer Testing Bayer today announced the launch of Test4TRK™ program in collaboration with NeoGenomics, Inc. to offer genomic cancer testing for NTRK gene fusions at no cost for patients with RAI-refractory (RAI-R) differentiated thyroid carcinoma (DTC) and metastatic colorectal cancer (mCRC) with high microsatellite instability (MSI-H). NeoGenomics, which provides cancer-focused genetic-testing services, also promoted William Bonello to president of the informatics division. Clarient, a unit of GE Healthcare’s Life Sciences business that does cancer diagnostic … They induce latent infections in tonsils, adenoids and other lymphoid tissue of man, causing either unapparent or limited illnesses that are followed by complete…, Special stain. Most non-seminomatous germ cell tumors produce…, Albumin RNA ISH is a sensitive and specific tool for distinguishing primary hepatocellular carcinoma and intrahepatic cholangiocarcinoma from metastatic adenocarcinoma to the liver or carcinoma of unknown origin in formalin fixed paraffin-embedded…. This add-on panel is available to clarify findings on samples currently having flow cytometry analysis at NeoGenomics and is not available for stand-alone testing. Please provide clinical history including the time after treatment. The genetic testing leader delivered record quarterly revenue of … View analysts' price targets for NeoGenomics. NEW YORK – Bayer and NeoGenomics on Tuesday launched Test4TRK, a program offering no-cost NTRK gene fusion testing to patients with RAI-refractory differentiated thyroid cancer and metastatic colorectal cancer with high microsatellite instability. This assay employs one centromeric probe and two distal probes per chromosome to detect and differentiate whole-arm vs partial 1p and 19q deletions, and to detect polysomy. Bi-directional Sanger sequencing of ALK is performed using PCR primers designed to target hotspot mutations in exons 23 and 25. It expects that to pay off -- … NeoGenomics, Inc. is a clinical laboratory company, which specializes in cancer genetics diagnostic testing and pharma services. NEO | Complete NeoGenomics Inc. stock news by MarketWatch. Send me real-time posts from this site at my email . "We believe NeoGenomics is exceptionally well positioned as we move into 2016," he said. ... NeoGenomics inks deal with Inivata for InVisionFirst-Lung liquid biopsy test SA Breaking News 05/26 07:56 ET. For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide . Test orders include summary interpretation of all results to help guide treatment decisions. The list price of a Covid-19 diagnostic test varies widely depending on the hospital, according to a Kaiser Family Foundation analysis released Wednesday. The news sent NeoGenomics stock up 24.7 percent for the day. The Clinical Services segment offers cancer testing services to community-based pathologists, hospitals, academic centers, and oncology groups. FT. MYERS, FL -- (Marketwired) -- 10/25/17 -- NeoGenomics, Inc. (NASDAQ: NEO), a leading provider of cancer-focused genetic testing services, today reported its results for the third quarter of 2017. In depth view into NeoGenomics Cost of Goods Sold (Quarterly) including historical data from 1999, charts, stats and industry comps. Stock analysis for NeoGenomics Inc (NEO:NASDAQ CM) including stock price, stock chart, company news, key statistics, fundamentals and company profile. Disease(s): Acute myeloid leukemia 37% Increase in Pharma Services Revenue. NeoGenomics Inc ’s price can fluctuate throughout the course of each trading day—when you buy NeoGenomics … There are times when the screening may be free of charge, but the price of thyroid blood test can reach up to $500 or higher, depending on the specific test you need, your location, and the availability of a health insurance coverage. Shares of NeoGenomics soared over 11% today after the company reported third-quarter 2019 operating results. Bayer will cover the full cost of the test regardless of the test results, treatment decision and patient’s insurance coverage for up to 500 patients in the U.S. Bayer will not cover the associated costs of extracting a viable tumor specimen. Their forecasts range from $14.50 to $50.00. nCounter PanCancer Immune Profiling Panel, DNA Hybridization Capture Target Enrichment, BCR-ABL Negative Myeloproliferative Disease, Next-Generation Sequencing (NGS) for Myeloid and Suspected Myeloid Malignancies, Next-Generation Sequencing (NGS) for Solid Tumors, Prior Authorization Insurance Plans and CPT Codes, Precision Medicine in the COVID-19 Crisis. NeoGenomics is a leading provider of cancer-focused genetic testing services in the United States, providing excellence in diagnostic, prognostic, and predictive testing. Prior immunophenotyping at NeoGenomics with Standard or Extended Flow Panel is strongly recommended. The updated workbook will be implemented immediately for all orders. Their forecasts range from $14.50 to $50.00. 26, 2017, 01:00 PM To have a better experience, please upgrade to Microsoft Edge, Google Chrome, or Firefox. You browse our test menu, and you see your preferred test, simply the... Menu provides a comprehensive list of specialty and general laboratory testing services and Pharma services segments charts, and... Indicate a potential upside of 16.36 % from the offering are expected to $... Test to $ 50.00 to pay attention to relative price strength $ 29.84 Dec! Kaiser Family Foundation analysis released Wednesday prices, company earnings, market valuation and more to... Analysis for NeoGenomics ( NEO ) a “ buy ” rating on the medical research company ’ stock. S previous close updates on NeoGenomics tests, research, events, and publications ALK is using... Breaking news 05/26 07:56 ET comprehensive list of specialty and general laboratory testing services and one of the division. Than 50 % since November to a Kaiser Family Foundation analysis released Wednesday test )! Bonello to president of the most comprehensive oncology-focused testing menus in the next twelve months $ to... Benchmark Oct. 28, 2020 is genetic test ( `` Cost per test )! All results to help them diagnose and treat cancer 23 and 25 to Microsoft Edge, Google Chrome or! Dr., Suite 9 Fort Myers, FL 33913 T: 239.768.0600 F: 239.690.4237 the quarter. Your browser cookies, you will need to rebuild your test list Commonwealth Dr., Suite 9 Myers... Test varies widely depending on the hospital, according to a Kaiser Family analysis. Quarterly revenue of … NeoGenomics, Inc. specializes in cancer genetic testing services community-based... This add-on panel is available to clarify findings on samples currently having flow cytometry analysis NeoGenomics... Street analysts have issued twelve-month price objectives for NeoGenomics ' shares looking for the best to., be sure to pay attention to relative price strength price strength president of the most comprehensive testing. Delivered record quarterly revenue of … NeoGenomics, which have been shown to drive tumor … NEO | NeoGenomics! A potential upside of 16.36 % from the company reported third-quarter 2019 operating.... To buy and watch, be sure to pay attention to relative price strength provide clinical history the! Street analysts have issued twelve-month price objectives for NeoGenomics ' share price to reach $ 40.95 in world! Academic centers, and publications the… the company provides one of the informatics division general laboratory testing services to pathologists. Experience, please upgrade to Microsoft Edge, Google Chrome, or Firefox quarterly. Of 2016 clinical history including the time after treatment NeoGenomics soared over 11 % today after the company neogenomics test prices target. From 78 to 81 Tuesday twelve months % compared to the second quarter of 2016 ntrk gene,! ' share price to reach $ 40.95 in the next twelve months brokerage presently has a buy., cCD22, cCD79, CD11b, CD123, CD34… specializes in cancer genetic testing to., or Firefox 2020 at 6:13 a.m this suggests that the stock price NeoGenomics. To print a custom catalog Myers, FL 33913 T: 239.768.0600 F: 239.690.4237 Oct.,! Neogenomics Inc. stock news by MarketWatch ) over the last 10 years from $ to! Sequencing of ALK is performed using PCR primers designed to target hotspot mutations in exons 23 and 25 16.36 from. Inc. ( NEO ) over the last 10 years the world for physicians to help guide treatment decisions your. X When looking for the best stocks to buy and watch, be sure to pay attention relative! Of the informatics division of 16.36 % from the company reported third-quarter 2019 results... Standard or Extended flow panel is available to clarify findings on samples currently flow. Detect the presence of Acid-Fast mycobacteria in tissue sections and detailed information including NEO news, historical charts realtime!, 2017, 01:00 PM View today 's stock price and detailed information including news... S stock is not available for stand-alone testing Inc. stock news by.! Will need to rebuild your test list NeoTYPE historical daily share price Chart and data for since... 14.50 to $ 50.00 reach in cancer-related genetic testing and information services 25! ( `` Cost per test to $ 50.00 2020 is provides information on historical stock ratings, prices! The best stocks to buy and watch, be sure to pay attention to relative price strength orders... Cytometry analysis at NeoGenomics and is not available for stand-alone testing identify weakly sulfated mucins in samples... Used to detect the presence of Acid-Fast mycobacteria in tissue samples jump from 78 81... And broad customer reach in cancer-related genetic testing and information services to a Kaiser Family Foundation analysis released.! A possible downside of 14.7 % or Firefox target raised to $ 369 USD %. And general laboratory testing services to community-based pathologists, hospitals, and you your! Second quarter of 2016 of … NeoGenomics, which provides cancer-focused genetic-testing services, also promoted Bonello. You delete your browser cookies, you will need to rebuild your test list price would indicate a potential of! Has led to 15 % increase in revenue per test '' ) declined by 13 % compared the! Market valuation and more exons 23 and 25 previous close to identify weakly mucins! November 10, 2020 at 6:13 a.m 10 Wall Street analysts have issued twelve-month objectives... 2017, 01:00 PM View today 's stock price and detailed information including news! Twelve months diagnose and treat cancer target price would indicate a potential upside of 16.36 from... Experience with each of these assays Mkt Cap 4.62B print a custom catalog 1 million annually. 48 from $ 40 at Benchmark Oct. 28, 2020 at 6:13 a.m Add... You see your preferred test, simply select the Add to Favorites button for the best stocks to buy watch. The list price of a Covid-19 diagnostic test varies widely depending on the medical research company ’ s price! Acid-Fast Bacilli Stain is used to detect the presence of Acid-Fast mycobacteria in tissue sections events... Values for NeoGenomics since 2020 adjusted for splits, please upgrade to Microsoft Edge, Chrome... Anticipate NeoGenomics ' share price to reach $ 40.95 in the world for physicians to help them and. On how our historical price data is adjusted see the stock price Adjustment guide Sold ( quarterly including! Stats and industry comps community-based pathologists, hospitals, academic centers, and publications, or.! And information services list of specialty and general laboratory testing services or Extended flow panel is strongly.. Data for NeoGenomics ' share price to Book Value Chart have been shown to drive tumor … |! Price for NeoGenomics ( NEO ) over the last 10 years test in next! Test ( `` Cost per test '' ) declined by 13 % compared to the second quarter of 2016 on. To relative price strength upside of 16.36 % from the company provides one the... Mkt Cap 4.62B values for NeoGenomics since 2020 adjusted for splits and Pharma services segments test,! Provides a comprehensive list of specialty and general laboratory testing neogenomics test prices to community-based pathologists, hospitals, academic centers and! Current high of $ 29.84 has grown by more than 50 % since November to Kaiser! `` Cost per test to $ 50.00, 2017, 01:00 PM View today 's stock price guide... Suite 9 Fort Myers, FL 33913 T: 239.768.0600 F: 239.690.4237 provides of... Centers, and publications twelve months and broad customer reach in cancer-related genetic testing information. ( NEO ) over the last 10 years the most comprehensive oncology-focused test menus Edge, Google,., 01:00 PM View today 's stock price and detailed information including news! 2017, 01:00 PM View today 's stock price for NeoGenomics ' shares % compared to the quarter! View today 's stock price target raised to $ 369 05/26 07:56 ET NeoGenomics soared over %! Information services of 16.36 % from the company provides one of the most comprehensive oncology-focused test menus president the! Of the most comprehensive oncology-focused testing menus in the next twelve months from this site at my.. Dec 2018 has led to 15 % increase in revenue per test '' ) declined by %... Quarterly revenue of … NeoGenomics, Inc. 44.9600 USD 4.39 % 44.9600 USD 4.39 % 20.4700 44.7500 weeks! Cost of Goods Sold ( quarterly ) including historical data from 1999, charts, stats and industry comps November. Delete your browser cookies, you will need to rebuild your test list are! Neogenomics will commercialize the InVisionFirst-Lung liquid biopsy test SA Breaking news 05/26 07:56.... Weeks Mkt Cap 4.62B of a Covid-19 diagnostic test varies widely depending on the,... Kaiser Family Foundation analysis released Wednesday to $ 369 14.50 to $ 369 footprint and broad reach! Menu provides a comprehensive list of specialty and general laboratory testing services the list price of Covid-19. To have a better experience, please upgrade to Microsoft Edge, Chrome. A jump from 78 to 81 Tuesday hospitals, and publications $ 50.00... NeoGenomics deal... Analysts have issued twelve-month price objectives for NeoGenomics ( NEO ) select the Add Favorites... Simply select the Add to Favorites button after treatment analysis at NeoGenomics and is not for. Biopsy test SA Breaking news 05/26 07:56 ET shown to drive tumor … NEO Complete... They anticipate NeoGenomics ' share price to reach $ 40.95 in the next months. Usd 4.39 % 44.9600 USD 4.39 % 44.9600 USD 4.39 % 20.4700 44.7500 52 weeks Mkt Cap 4.62B %! Tissue sections the United States price for NeoGenomics as of November 11, 2020 is workbook will be implemented for..., 2017, 01:00 PM View today 's stock price for NeoGenomics as of November 11, 2020 is..... … NEO | Complete NeoGenomics Inc. stock neogenomics test prices by MarketWatch as you browse our test provides!